Spire Wealth Management Anixa Biosciences Inc Transaction History

Spire Wealth Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 03, 2023	SELL	$3.78 - $5.81 $45,360 - $69,720	-12,000 Reduced 82.76%	2,500 $11,000
Q3 2021 Oct 22, 2021	SELL	$3.57 - $5.6 $10,710 - $16,800	-3,000 Reduced 17.14%	14,500 $69,000
Q2 2021 Jul 26, 2021	SELL	$3.46 - $4.92 $23,528 - $33,456	-6,800 Reduced 27.98%	17,500 $68,000
Q1 2021 May 21, 2021	BUY	$3.27 - $7.14 $79,461 - $173,502	24,300 New	24,300 $114,000

5.52M

21K

6.7K

Ticker ANIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,661,700
Market Cap $88.3M
Description
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Spire Wealth Management with notifications on news.